1. Home
  2. TSEM vs VTRS Comparison

TSEM vs VTRS Comparison

Compare TSEM & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tower Semiconductor Ltd.

TSEM

Tower Semiconductor Ltd.

N/A

Current Price

$146.39

Market Cap

18.9B

Sector

Technology

ML Signal

N/A

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$20.79

Market Cap

21.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TSEM
VTRS
Founded
1993
1961
Country
Israel
United States
Employees
N/A
30000
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9B
21.0B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
TSEM
VTRS
Price
$146.39
$20.79
Analyst Decision
Strong Buy
Buy
Analyst Count
9
12
Target Price
★ $275.21
$21.00
AVG Volume (30 Days)
3.2M
★ 9.0M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
★ 2.32%
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $14,299,900,000.00
Revenue This Year
$27.80
$3.53
Revenue Next Year
$39.15
$3.69
P/E Ratio
$66.16
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$87.30
$10.15
52 Week High
$319.94
$21.20

Technical Indicators

Market Signals
Indicator
TSEM
VTRS
Relative Strength Index (RSI) 38.79 71.15
Support Level $129.95 $16.02
Resistance Level $196.51 N/A
Average True Range (ATR) 13.36 0.58
MACD 0.33 0.17
Stochastic Oscillator 24.01 87.62

Price Performance

Historical Comparison
TSEM
VTRS

About TSEM Tower Semiconductor Ltd.

Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs) based on the design specifications of customers. The company's line of integrated circuits is incorporated into markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

Share on Social Networks: